The effect of amfonelic acid or nisoxetine in combination with morphine on brain-stimulation reward

Sari E Izenwasser, Conan Kornetsky

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Many drugs of abuse, including stimulants such as cocaine and amphetamine, and opioids like morphine and heroin, will lower the threshold at which rats will work to receive electrical stimulation to the medial forebrain bundle-lateral hypothalamic region (MFB-LH). This effect is even greater when the two classes of drugs are coadministered. The underlying mechanisms by which this occurs are not completely understood, however there is considerable evidence suggesting that the catecholamines play a major role in mediating the reinforcing effects of these drugs. The present study was conducted to investigate the effects of amfonelic acid, an indirect dopamine agonist, and nisoxetine, a highly selective norepinephrine uptake blocker, alone and in combination with morphine, on the reward threshold for rewarding electrical intracranial stimulation. As in previous studies, morphine, as well as amfonelic acid, lowered the reward threshold with the amfonelic acid causing greater threshold lowerings than that of morphine. When a low (ineffective) dose of amfonelic acid was administered concomitantly with morphine, the threshold lowerings observed were larger than those seen with either drug alone and were often more than additive. Nisoxetine alone had no effect on the reward threshold and produced inconsistent results when combined with morphine. These findings support the thesis that amfonelic acid has abuse potential, and that its reinforcing effects may, in fact, be even greater than that of the opioids. Further, these results support the hypothesis that dopamine plays a more critical role in mediating brain-stimulation reward than dose norepinephrine.

Original languageEnglish
Pages (from-to)983-986
Number of pages4
JournalPharmacology, Biochemistry and Behavior
Volume32
Issue number4
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

nisoxetine
Reward
Morphine
Brain
Opioid Analgesics
Electric Stimulation
Norepinephrine
Pharmaceutical Preparations
Medial Forebrain Bundle
Heroin
Dopamine Agonists
Street Drugs
Amphetamine
Cocaine
Catecholamines
amfonelic acid
Rats
Dopamine

Keywords

  • Amfonelic acid
  • Brain-stimulation reward
  • Morphine
  • Nisoxetine

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

The effect of amfonelic acid or nisoxetine in combination with morphine on brain-stimulation reward. / Izenwasser, Sari E; Kornetsky, Conan.

In: Pharmacology, Biochemistry and Behavior, Vol. 32, No. 4, 01.01.1989, p. 983-986.

Research output: Contribution to journalArticle

@article{f31153e4a3fe4360a89701d988ea970f,
title = "The effect of amfonelic acid or nisoxetine in combination with morphine on brain-stimulation reward",
abstract = "Many drugs of abuse, including stimulants such as cocaine and amphetamine, and opioids like morphine and heroin, will lower the threshold at which rats will work to receive electrical stimulation to the medial forebrain bundle-lateral hypothalamic region (MFB-LH). This effect is even greater when the two classes of drugs are coadministered. The underlying mechanisms by which this occurs are not completely understood, however there is considerable evidence suggesting that the catecholamines play a major role in mediating the reinforcing effects of these drugs. The present study was conducted to investigate the effects of amfonelic acid, an indirect dopamine agonist, and nisoxetine, a highly selective norepinephrine uptake blocker, alone and in combination with morphine, on the reward threshold for rewarding electrical intracranial stimulation. As in previous studies, morphine, as well as amfonelic acid, lowered the reward threshold with the amfonelic acid causing greater threshold lowerings than that of morphine. When a low (ineffective) dose of amfonelic acid was administered concomitantly with morphine, the threshold lowerings observed were larger than those seen with either drug alone and were often more than additive. Nisoxetine alone had no effect on the reward threshold and produced inconsistent results when combined with morphine. These findings support the thesis that amfonelic acid has abuse potential, and that its reinforcing effects may, in fact, be even greater than that of the opioids. Further, these results support the hypothesis that dopamine plays a more critical role in mediating brain-stimulation reward than dose norepinephrine.",
keywords = "Amfonelic acid, Brain-stimulation reward, Morphine, Nisoxetine",
author = "Izenwasser, {Sari E} and Conan Kornetsky",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0091-3057(89)90070-1",
language = "English",
volume = "32",
pages = "983--986",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - The effect of amfonelic acid or nisoxetine in combination with morphine on brain-stimulation reward

AU - Izenwasser, Sari E

AU - Kornetsky, Conan

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Many drugs of abuse, including stimulants such as cocaine and amphetamine, and opioids like morphine and heroin, will lower the threshold at which rats will work to receive electrical stimulation to the medial forebrain bundle-lateral hypothalamic region (MFB-LH). This effect is even greater when the two classes of drugs are coadministered. The underlying mechanisms by which this occurs are not completely understood, however there is considerable evidence suggesting that the catecholamines play a major role in mediating the reinforcing effects of these drugs. The present study was conducted to investigate the effects of amfonelic acid, an indirect dopamine agonist, and nisoxetine, a highly selective norepinephrine uptake blocker, alone and in combination with morphine, on the reward threshold for rewarding electrical intracranial stimulation. As in previous studies, morphine, as well as amfonelic acid, lowered the reward threshold with the amfonelic acid causing greater threshold lowerings than that of morphine. When a low (ineffective) dose of amfonelic acid was administered concomitantly with morphine, the threshold lowerings observed were larger than those seen with either drug alone and were often more than additive. Nisoxetine alone had no effect on the reward threshold and produced inconsistent results when combined with morphine. These findings support the thesis that amfonelic acid has abuse potential, and that its reinforcing effects may, in fact, be even greater than that of the opioids. Further, these results support the hypothesis that dopamine plays a more critical role in mediating brain-stimulation reward than dose norepinephrine.

AB - Many drugs of abuse, including stimulants such as cocaine and amphetamine, and opioids like morphine and heroin, will lower the threshold at which rats will work to receive electrical stimulation to the medial forebrain bundle-lateral hypothalamic region (MFB-LH). This effect is even greater when the two classes of drugs are coadministered. The underlying mechanisms by which this occurs are not completely understood, however there is considerable evidence suggesting that the catecholamines play a major role in mediating the reinforcing effects of these drugs. The present study was conducted to investigate the effects of amfonelic acid, an indirect dopamine agonist, and nisoxetine, a highly selective norepinephrine uptake blocker, alone and in combination with morphine, on the reward threshold for rewarding electrical intracranial stimulation. As in previous studies, morphine, as well as amfonelic acid, lowered the reward threshold with the amfonelic acid causing greater threshold lowerings than that of morphine. When a low (ineffective) dose of amfonelic acid was administered concomitantly with morphine, the threshold lowerings observed were larger than those seen with either drug alone and were often more than additive. Nisoxetine alone had no effect on the reward threshold and produced inconsistent results when combined with morphine. These findings support the thesis that amfonelic acid has abuse potential, and that its reinforcing effects may, in fact, be even greater than that of the opioids. Further, these results support the hypothesis that dopamine plays a more critical role in mediating brain-stimulation reward than dose norepinephrine.

KW - Amfonelic acid

KW - Brain-stimulation reward

KW - Morphine

KW - Nisoxetine

UR - http://www.scopus.com/inward/record.url?scp=0024360918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024360918&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(89)90070-1

DO - 10.1016/0091-3057(89)90070-1

M3 - Article

VL - 32

SP - 983

EP - 986

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 4

ER -